5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 9.95▼ | 9.91▼ | 9.91▼ | 10.05▼ | 9.50▲ |
MA10 | 9.91▼ | 9.95▼ | 9.99▼ | 9.95▼ | 10.51▼ |
MA20 | 9.96▼ | 10.04▼ | 10.07▼ | 9.58▲ | 11.50▼ |
MA50 | 10.09▼ | 10.07▼ | 9.95▼ | 10.59▼ | 13.26▼ |
MA100 | 10.02▼ | 9.67▲ | 9.51▲ | 11.60▼ | 12.21▼ |
MA200 | 9.76▲ | 9.41▲ | 10.06▼ | 12.87▼ | 15.86▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.004▲ | -0.025▼ | -0.040▼ | 0.143▲ | -0.196▼ |
RSI | 44.665▼ | 45.074▼ | 46.059▼ | 48.151▼ | 39.335▼ |
STOCH | 45.128 | 32.440 | 28.274 | 61.367 | 22.168 |
WILL %R | -90.476▼ | -73.214 | -73.214 | -42.857 | -71.496 |
CCI | -55.613 | -79.049 | -98.601 | 32.885 | -64.485 |
CDL | $GLSI Doji Candlestick Pattern Detected | Set Alert |
Thursday, April 24, 2025 05:00 PM
STAFFORD, Texas, April 03, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial ...
|
Thursday, April 24, 2025 05:00 PM
STAFFORD, Texas, April 03, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial ...
|
Wednesday, April 23, 2025 05:00 PM
Greenwich LifeSciences, Inc. (NASDAQ:GLSI – Free Report) – Analysts at HC Wainwright cut their Q1 2025 earnings estimates for shares of Greenwich LifeSciences in a research report issued on ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
02/05/25 | 9.87 | 9.87 | 9.87 | 9.87 | 6,202 |
01/05/25 | 10.00 | 10.23 | 9.68 | 9.98 | 23,733 |
30/04/25 | 10.15 | 10.28 | 9.944 | 10.10 | 26,300 |
29/04/25 | 10.02 | 10.365 | 10.02 | 10.24 | 56,243 |
28/04/25 | 9.99 | 10.12 | 9.649 | 10.04 | 37,000 |
25/04/25 | 10.27 | 10.34 | 9.6439 | 9.98 | 62,586 |
24/04/25 | 9.80 | 10.86 | 9.80 | 10.44 | 89,900 |
23/04/25 | 9.92 | 10.12 | 9.48 | 9.85 | 217,509 |
22/04/25 | 9.44 | 9.90 | 9.09 | 9.63 | 110,900 |
21/04/25 | 9.05 | 9.38 | 8.755 | 9.34 | 96,200 |
|
|
||||
|
|
||||
|
|